Product Description
Pharmaceutical
Raw Materials and Intermediates
AI Product Description
*The following content is generated by AI and is for reference only.
Torasemi is not a recognized chemical compound, pharmaceutical agent, or industrial product in global scientific databases such as PubChem, CAS Registry, or major regulatory bodies like the FDA and EMA. Extensive searches across authoritative sources reveal no existing substance, material, or commercial entity by this specific name. It appears "Torasemi" may be a misspelling of Torasemide (CAS No. 60842-91-3), a widely used loop diuretic medication primarily employed to treat fluid retention (edema) associated with heart failure, liver cirrhosis, and kidney disorders. Torasemide functions by inhibiting sodium and chloride reabsorption in the thick ascending limb of the loop of Henle in the kidney, promoting increased excretion of water and electrolytes. Its molecular formula is C₁₂H₁₄N₆O₃S₂, and it possesses a longer half-life compared to furosemide, allowing for once-daily dosing in many clinical scenarios. The drug is available in oral tablet and intravenous formulations and is valued for its potent diuretic effect with potentially fewer metabolic side effects. If "Torasemi" refers to a proprietary brand name, a regional variation, or a fictional product, no standard chemical data exists under that exact designation. In the absence of verified information, providing specific molecular weights, safety profiles, or industrial applications would be scientifically inaccurate. Researchers and healthcare professionals should verify nomenclature through official pharmacopoeias or manufacturer documentation before proceeding with any analysis. For accurate medical or chemical guidance, consulting peer-reviewed literature or contacting regulatory agencies is strongly recommended. This clarification ensures public safety and prevents misinformation regarding unverified substances.